Prostaglandins may inhibit or promote tumor cell replication, depending on the cell system that is investigated. In our laboratory, we have established and characterized four different specific human cancer cell lines. The objectives of this study were to examine and compare the prostaglandin endoperoxide synthase (PG synthase, EC 1.14.99.1) activity of these cell lines by measuring the conversion of arachidonate to 3H-PGE2 and 3H-PGF2α. We found that the oral epidermal carcinoma cell line (OEC-M1) had a moderate degree of PG synthase activity. Enzyme activity could be partially blocked (statistically significant) by the addition of epidermal growth factor (EGF) at 20 ng/mL and almost completely inhibited by platelet-derived growth factor at (PDGF) 20 mU/mL. By contrast, we discovered that the human breast adenocarcinama cell line (BC-M1) did not contain significant PG synthase, and enzyme activity could be significantly activated by the addition of epidermal growth factor at 20 ng/mL and platelet-derived growth factor at 20 mU/mL. We also found that the human stomach adenocarcinoma cell line (SCM-1) had a significant amount of PG synthase activity, and these PG synthase activities were not activated or inhibited by EGF at 20 ng/mL or PDGF at 20 mU/mL. Furthermore, the human fibrosarcoma (FS-Ml) cell line also contained a moderate degree of PG synthase activity, which could be significantly inhibited by PDGF at 20 mU/mL but was not inhibited by EGF at 20 ng/mL. The results suggest that EGF and PDGF may be involved in the regulation of the PG synthase activities of human oral, breast, stomach, and fibrosarcoma cancer cells.
Anggard E., Bohman SO, Griffin JE, Larsson C., Maunsbach AB (1972). Subcellular localization of the prostaglandin system in the rabbit renal papilla. Acta Physiol Scand84:231-246.
2.
Berens ME, Salmon SE, Davis TP (1984). Quantitative analysis of prostaglandins in cell culture medium by high-resolution gas chromatography with electron-capture detection. J Chromatogr307:251-260.
3.
Bergstrom S., Carlson LA, Weeks JR (1968). The prostaglandins: a family of biologically active lipids. Pharmacol Rev20:1-48.
4.
Bhana D., Hillier K., Karim SMM (1971). Vasoactive substances in Kaposi's sarcoma. Cancer27:233-237.
5.
Bockman RS, Myers WPL (1977). Osteoporism of human breast cancer. Prog Cancer Res5:431-450.
6.
Bradford MM (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem72:248-254.
7.
Byyny RL, Orth DL, Cohen S., Doyne ES (1974). Epidermal growth factor: effects of endrogens and androgenic agents. Endocrinology95:776-782.
8.
Cammarata PR, Yorio T. (1990). L-buthionine sulfoximine-induced loss of glutathione does not elicit PGH synthase inactivation in cultured bovine lens epithelial cells. J Ocular Pharmacol6 :43-49.
9.
Carpenter G., Cohen S. (1979). Epidermal growth factor. Ann Rev Biochem48:193-216.
10.
Chang GG, Wang JK, Huang TM, Lee HJ, Chou WY, Meng CL ( 1991). Purification and characterization of the cytosolic NADP+dependent malic enzyme from human breast cancer cell line. Eur J Biochem202:681-688.
11.
Christ EJ, Nugteren DH (1970). The biosynthesis and possible function of prostaglandins in adipose tissue. Biochim Biophys Acta218:296-307.
12.
Cummings KB, Robertson RP (1977). Prostaglandin: increased production by renal cell carcinoma. J Urol118:720-723.
13.
Danon A., Zenser TV, Thomasson DL, Davis BB (1986). Eicosanoid synthesis by cultured human urothelial cells: potential role in bladder cancer. Cancer Res46:5676-5681.
14.
Demers LM, Allegra JC, Harvey HA, Lipton A., Luderer JR, Mortel R., et al. (1977). Plasma prostaglandins in hypercalcemic patients with neoplastic disease. Cancer39:1559-1562.
15.
DeWitt DL, Rollins TE, Day JS, Gauger JA, Smith WL (1981). Orientation of the active site and antigenic determinants of prostaglandin endoperoxide synthase in the endoplasmic reticulum. J Biol Chem256:10375-10382.
16.
Donati MB, Rotilio D., Delaini F., Giavazzi R., Mantovani A., Poggi A. (1982). Animal models for the study of platelet-tumor cell interactions. In: Interactions of platelets and tumor cells. Jamieson GA, editor. New York: Alan Liss Inc., pp. 159-176.
17.
ElAttar TM (1976). Prostaglandin E2 in human gingiva in health and disease and its stimulation by female sex steroids. Prostaglandins11:331-341.
18.
Fidler IJ (1978). Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res38:2651-2660.
19.
Fiedler L., Zahradnik HP, Schlegel H. (1980). Perioperative behaviour of prostaglandin E2 and 13,14-dihydro-15-keto-PGF2α in serum of bronchial carcinoma patients. In: Advances in prostaglandin and thromboxane research. Samuelsson B, Paoletti R , editors. New York: Raven Press , pp. 6, 585-586.
20.
Fitzpatrick FA, Stringfellow DA (1979). Prostaglandin D2 formation by malignant melanoma cells correlates inversely with cellular metastatic potential. Proc Natl Acad Sci USA76 :1765-1769.
21.
Fukushima M., Kato T., Ueda R., Ota K., Narumiya S., Hayashi O. (1982). Prostaglandin D2, a potential antineoplastic agent . Biochem Biophys Res Commun105:956-964.
22.
Goldhaber P. (1960). Enhancement of bone resorption in tissue culture by mouse fibrosarcoma. Proc Am Assoc Cancer Res3:113.
23.
Gregory H. (1975). Isolation and structure of urogastrone and its relationship to epidermal growth factor. Nature257:325-327.
24.
Gullick WJ, Marsden JJ, Whittle N., Ward B., Bobrow B., Waterfield MD (1986). Expression of epidermal growth factor receptors on human cervical, ovarian, and vulval carcinomas. Cancer Res46:285-292.
25.
Hamasaki Y., Kitzler J., Hardman R., Nettesheim P., Eling TE (1993). Phorbol ester and epidermal growth factor enhance the expression of two inducible prostaglandin H synthase genes in rat tracheal epithelial cells. Arch Biochem Biophys304 :226-234.
26.
Hamburger AW, White CP, Brown RW (1981). Effect of epidermal growth factor on proliferation of human tumor cells in soft agar. J Natl Canc Inst67:825-830.
27.
Hammarstrom S., Samuelsson B., Bjursell G. (1973). Prostaglandin levels in normal and transformed baby-hamster-kidney fibroblasts. Nature (New Biol)243:50-51.
28.
Hamprecht B., Jaffe BM, Philpott GW (1973). Prostaglandin production by neuroblastoma, glioma and fibroblast cell lines, stimulation by N6, O2- dibutyryl adenosine 3',5'-cyclic monophosphate. FEBS Lett36:193-198.
29.
Heath JK, Atkinson SJ, Hembry RM, Reynolds JJ, Meikle MC (1987). Bacterial antigens induce collagenase and prostaglandin E2 synthesis in human gingiva fibroblasts through a primary effect on circulating mononuclear cells. Infect Immun55 :2148-2154.
30.
Heldin CH, Westermark B., Wasteson A. (1981). Platelet-derived growth factor. Isolation by a large scale procedure and analysis of subunit composition. Biochem J193:907-913.
31.
Holtzman MJ, Turk J., Shornick LP (1992). Identification of a pharmacologically distinct prostaglandin H synthase in cultured epithelial cells. J Biol Chem267:21438-21445.
32.
Honn KV ( 1982). Prostacyclin/thromboxane ratios in tumor growth and metastasis . In: Prostaglandins and cancer. Powles TJ, Bockman RJ, Honn KV, Ramwell PW, editors. New York: Alan Liss Inc., pp. 733-752.
33.
Honn KV, Bockman RS, Marnett LJ (1981a). Prostaglandins and cancer: a review of tumor initiation through tumor metastasis. Prostaglandins21:833-864.
34.
Honn KV, Cicone B., Skoff A. (1981b). Prostacyclin: a potent antimetastatic agent. Science212:1270-1272.
35.
Ichikawa Y. (1969). Differentiation of a cell line in myeloid leukemia . J Cell Physiol74:233-234.
36.
Jaffe BM, Condon S. (1976). Prostaglandins E and F in endocrine diarrheagenic syndromes. Ann Surg184:516-524.
37.
Jaffe BM, Parker CW, Philpott GW (1971). Immunochemical measurement of prostaglandin or prostaglandin-like activity from normal and neoplastic cultured tissue. Surg Forum22:90-92.
38.
Kam PL, Lin CC, Li JC, Meng CL, Chang GG (1988). High malic enzyme activity in tumor cells and its cross-reaction with anti-pigeon liver malic enzyme serum. Molec Cell Biochem79:171-179.
39.
Karmali RA, Wustrow T., Thaler HT, Strong EW (1984). Prostaglandins in carcinomas of the head and neck . Cancer Lett22:333-336.
40.
Karmali RA, Choi K., Otter G., Schmid F. (1986). Eicosanoids and metastasis: experimental aspects in Lewis lung carcinoma. Cancer Biochem Biophys9:97-104.
41.
Kawamura M., Koshihara Y. (1983). Prostaglandin D2 strongly inhibits growth of murine mastocytoma cells. Prostaglandins Leukotrienes Med12:85-93.
42.
Kikuchi Y., Miyachi M., Omori K., Kita T., Kizawa I., Kato K. ( 1986). Inhibition of human ovarian cancer cell growth in vitro and in nude mice by prostaglandin D2. Cancer Res46:3364-3366.
43.
Kokama Y., Cripps C., Sumida K., Mookini RK, Oishi N., Kimura LH, Kobara TY (1981). Significant increase of plasma prostaglandins in cancer patients. Res Commun Chem Pathol Pharmacol31:379-382.
44.
Lee K., Tanaka M., Shigeno C., Yamamoto I., Ohta S., Rikimaru K., et al. (1990). Epidermal growth factor stimulates the anchorage-independent growth of human squamous cell carcinomas overexpressing its receptors. Biochem Biophys Res Commun168:905-911.
45.
Levine L., Hinkle PM, Voelkel EF, Tashjian AH, Jr (1972). Prostaglandin production by mouse fibrosarcoma cells in culture: inhibition by indomethacin and aspirin. Biochem Biophys Res Commun47:888-896.
46.
Meng CL, Chao CF, Tu CL, Chang LC (1984). Establishment and characterization of a human oral epidermoid carcinoma cell line. Chin Dent J4:103-105.
47.
Miyamoto T., Ogino N., Yamamoto S., Hayashi O. (1976). Purification of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes. J Biol Chem251:2629-2636.
48.
Moyer MP (1984). A rapid, reproducible method for processing human solid tumors for in vitro culture. J Tissue Culture Meth8:63-67.
49.
Nigam S. (1987). Extraction of eicosanoids from biological samples . In: Prostaglandins and related substances: a practical approach . Benedetto C, McDonald-Gilson RG, Nigam S, Slater TF, editors. Oxford, England: IRL Press Limited, pp. 45-52.
50.
Piper P., Vane J. ( 1971). The release of prostaglandins from lung and other tissues . Ann NY Acad Sci180:363-385.
51.
Prasad KN (1972). Morphological differentiation induced by prostaglandin in mouse neuroblastoma cells in culture. Nature (New Biol)236:49-52.
52.
Ritzi EM, Boto WO, Stylos WA (1975). Measurement of initial prostaglandin F metabolites in medium of BALB/c 3T3 and SV 3T3 mouse fibroblast cultures. Biochem Biophys Res Commun63:179-186.
53.
Rodan SB, Rodan GA, Simmons HA, Walenga RW, Feinstein MB, Raisz LG (1981). Bone resorptive factor produced by osteosarcoma cells with osteoblastic features is PGE2. Biochem Biophys Res Commun102:1358-1365.
54.
Rollins TE, Smith WL (1980). Subcellular localization of prostaglandin-forming cyclooxygenase in Swiss Mouse 3T3 fibroblasts by electron microscopic immunocytochemistry . J Biol Chem255:4872-4875.
55.
Ross R., Bowen-Pope DF, Raines EW (1985). Platelet-derived growth factor: its potential roles in wound healing, atherosclerosis, neoplasia, and growth and development . Ciba Foundation Symposium116:98-112.
56.
Sakai T., Yamaguchi N., Kawai K., Nishino H., Iwashima A. (1983). Prostaglandin D2 inhibits the proliferation of human neuroblastoma cells. Cancer Lett17:289-294.
57.
Santoro MG, Philpott GW, Jaffe BM (1976). Inhibition of tumor growth in vivo and in vitro by prostaglandin E. Nature263:777-779.
58.
Santoro MG, Philpott GW, Jaffe BM (1977). Inhibition of B-16 melanoma growth in vivo by a synthetic analog of prostaglandin E2. Cancer Res37:3774-3779.
59.
Santoro MG, Benedetto A., Jaffe BM (1979). Prostaglandin A1 induces differentiation in Friend erythroleukemia cells. Prostaglandins17:719-727.
60.
Seyberth HW, Segre GV, Morgan JL, Sweetman BJ, Potts JT Jr, Oates JA (1975). Prostaglandins as mediators of hypercalcemia associated with certain types of cancer. New Engl J Med293:1278-1283.
61.
Shupnik MA, Tashjian AH Jr (1981). Functional receptors for epidermal growth factor on human osteosarcoma cells. J Cell Physiol109:403-410.
62.
Simmet T., Jaffe BM (1983). Inhibition of B-16 melanoma growth in vitro by prostaglandin D2. Prostaglandins25:47-54.
63.
Stringfellow DA, Fitzpatrick FA (1979). Prostaglandin D2 controls pulmonary metastasis of malignant melanoma cells. Nature (Lond) 282:76-78.
64.
Tanaka Y., Ward SL, Smith WL (1987). Immunochemical and kinetic evidence for two different prostaglandin H-prostaglandin E isomerases in sheep vesicular gland microsomes . J Biol Chem262:1374-1381.
65.
Tashjian AH Jr, Voelkel EF, Levine L., Goldhaber P. (1972). Evidence that the bone resorption-stimulating factor produced by mouse fibrosarcoma cells is prostaglandin E2. A new model for the hypercalcemia of cancer. J Exp Med136:1329-1343.
66.
Thomas DR, Philpott GW, Jaffe BM (1974). The relationship of concentration of prostaglandin E and rates of cell replication. Exp Cell Res84:40-46.
67.
Tisdale MJ (1983). Role of prostaglandins in metastatic dissemination of cancer. Minireview on cancer research. Exp Cell Biol51:250-256.
68.
Trevisani A., Ferretti E., Capuzzo A., Tomasi V. (1980). Elevated levels of PGE2 in Yoshida hepatoma and the inhibition of tumor growth by non-steroid anti-inflammatory drugs. Br J Cancer41:341-347.
69.
Vanderveen EE, Grekin RC, Swanson NA, Kragballe K. (1986). Arachidonic acid metabolites in cutaneous carcinomas. Evidence suggesting that elevated levels of prostaglandins in basal cell carcinomas are associated with an aggressive growth pattern. Arch Dermatol122:407-412.
70.
Williams ED, Karim SMM, Sandler M. (1968). Prostaglandin secretion by medullary carcinoma of the thyroid. Lancet1:22-23.
71.
Yang TJ, Dale JB, Machanoff R. (1976). Effects of prostaglandins E1, E2, and F2α on the growth of leukemia cells in culture. J Cell Sci20:199-206.
72.
Yang CY, Gonnerman WA, Taylor L., Nimberg RB, Polgar PR (1987). Synthetic human parathyroid hormone fragment stimulates prostaglandin E2 synthesis by chick calvariae. Endocrinology120:63-70.
73.
Yang CY, Meng CL, Wong PYK (1993). Human parathyroid hormone fragment stimulates the de novo synthesis of prostaglandin endoperoxide synthase in chick calvaria . Mediators Inflammation2:143-147.
74.
Yunis JJ (1981). New chromosome techniques in the study of human neoplasia. Hum Pathol12:540-549.
